Douglas Kirk Ways insider trades
Open-market stock purchases and sales by Douglas Kirk Ways, Interim Chief Medical Officer at Spruce Biosciences, Inc, from SEC Form 4 filings since Dec 11, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 11, 2025 | SPRB Spruce Biosciences, Inc | Bought (not open market) | — |
| Dec 11, 2025 | SPRB Spruce Biosciences, Inc | Bought (not open market) | — |
| Dec 11, 2025 | SPRB Spruce Biosciences, Inc | Bought (not open market) | $27.7K |
| Dec 11, 2025 | SPRB Spruce Biosciences, Inc | Sold (not open market) | $210K |
| Dec 11, 2025 | SPRB Spruce Biosciences, Inc | Bought (not open market) | $41.7K |
| Dec 11, 2025 | SPRB Spruce Biosciences, Inc | Sold (not open market) | $67.8K |
Companies traded
- SPRB Spruce Biosciences, Inc: other filings, last Dec 11, 2025